SYBLEU Inc (SYBE)
OTC
Healthcare
Biotechnology
$0.06
▲ +0.00%
Market Cap
$583,742
Sector
Healthcare
Industry
Biotechnology
Beta
1.68
52-Wk Range
0.041-0.055
CEO
Joseph G. Vaini
Country
US
Currency
USD
SYBLEU Inc operates in the Biotechnology industry of the Healthcare sector, headquartered in Bronx, NY, US. The stock last traded at $0.06, up 0.00% on the session, giving a market capitalisation of $583,742. On trailing twelve-month figures it carries a trailing P/E of -3.14, a net margin of -1541.6%. Its beta of 1.68 implies it has historically moved more than the broad market.
Valuation & profitability (TTM)
P/E
-3.14
Price / Sales
49.91
Price / Book
-2.14
EV / EBITDA
-4.85
Gross margin
100.0%
Operating margin
-1275.5%
Net margin
-1541.6%
Return on equity
—
Debt / equity
-0.53
Current ratio
0.31
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
2
IPO date
2023-05-30
Headquarters
Bronx, NY, US
About SYBLEU Inc
Established in 2020, SYBLEU Inc. specializes in developing regenerative medical applications. The firm's headquarters are located in Bronx, New York.
Comparable companies
SYBLEU Inc is most often compared with the following Healthcare names:
More research on SYBE
Open full interactive analysis & DCF →